Important pharmacy news and late-breaking industry information updated daily.

FDA has approved a supplemental application for the human papillomavirus 9-valent vaccine, recombinant (Gardasil 9—Merck, Sharp & Dohme Corp.) to widen the approved use of the vaccine to include women and men aged 27–45 years.

CVS Health and Aetna on Thursday asked the Connecticut Insurance Department to approve their $69 billion merger, while independent pharmacists told the regulators the company resulting from the merger would threaten their businesses.

Several provisions will have a direct effect on pharmacists

What are the challenges providing older adults with optimal type 2 diabetes care?

The Senate on Wednesday by a vote of 98-1 passed legislation aimed at fighting the opioid crisis, sending the measure to President Trump's desk. The 660-page bill cracks down on illicit opioids being imported by mail from other countries and fueling the epidemic.

New CDC research highlights the increasing popularity of Juul e-cigarettes, finding that sales of the device rose more than seven-fold from 2016 to 2017. "The popularity of Juul among kids threatens our progress in reducing youth e-cigarette use," said Robert Redfield, MD, director of CDC.

MMWR: Vaccination far more likely in settings where it’s required

APhA is taking advantage of October being American Pharmacists Month by highlighting pharmacists' role and contribution to public health, especially in light of this summer's intense weather events.

Broad agreement opens possibility for a range of pharmacist-provided services

FDA has approved cemiplimab-rwlc (Libtayo—Regeneron Pharmaceuticals) injection for the treatment of individuals with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not eligible for curative surgery or curative radiation. This is the first FDA approval of a drug specifically for advanced CSCC.